(Q37776720)

23 August 2017

1 reference

title

Human papillomavirus vaccines in plants (English)

1 reference

23 August 2017

1 reference

3

Edward P Rybicki

1 reference

23 August 2017

Colomba Giorgi

1

1 reference

23 August 2017

Rosella Franconi

series ordinal

2

1 reference

23 August 2017

publication date

1 August 2010

1 reference

Expert Review of Vaccines

23 August 2017

published in

1 reference

23 August 2017

volume

9

1 reference

23 August 2017

issue

8

1 reference

23 August 2017

page(s)

913-924

1 reference

Neutralization of animal virus infectivity by antibody

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Vaccines: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Chapter 17: Second generation HPV vaccines to prevent cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Recombinant vaccines for the prevention of human papillomavirus infection and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Mechanisms of human papillomavirus-induced oncogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

The biological properties of E6 and E7 oncoproteins from human papillomaviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Therapeutic vaccination for HPV induced cervical cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Development of therapeutic HPV vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Different spectra of therapeutic vaccine development against HPV infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Long-term protection against human papillomavirus e7-positive tumor by a single vaccination of adeno-associated virus vectors encoding a fusion protein of inactivated e7 of human papillomavirus 16/18 and heat shock protein 70.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Therapeutic human papillomavirus DNA vaccination strategies to control cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Advances in dendritic-cell-based therapeutic vaccines for cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Plant-produced vaccines: promise and reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Recent progress in the development of plant derived vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Plants as bioreactors: Recent developments and emerging opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Third International Conference on Plant-Based Vaccines and Antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Plant-made vaccines for humans and animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Oral vaccination of mice with human papillomavirus virus-like particles induces systemic virus-neutralizing antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Expression of Human papillomavirus type 16 major capsid protein in transgenic Nicotiana tabacum cv. Xanthi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Oral immunogenicity of human papillomavirus-like particles expressed in potato

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Production of human papillomavirus type 16 virus-like particles in transgenic plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Protection of rabbits against cutaneous papillomavirus infection using recombinant tobacco mosaic virus containing L2 capsid epitopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Plant-produced cottontail rabbit papillomavirus L1 protein protects against tumor challenge: a proof-of-concept study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Expression of HPV-11 L1 protein in transgenic Arabidopsis thaliana and Nicotiana tabacum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Plant-based production of biopharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

High level protein expression in plants through the use of a novel autonomously replicating geminivirus shuttle vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Translational fusion of chloroplast-expressed human papillomavirus type 16 L1 capsid protein enhances antigen accumulation in transplastomic tobacco.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Insights into the role and function of L2, the minor capsid protein of papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

A papillomavirus-like particle (VLP) vaccine displaying HPV16 L2 epitopes induces cross-neutralizing antibodies to HPV11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: safety and immunogenicity in a phase I clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Prevention of cervical cancer through papillomavirus vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

The expression of a single-chain Fv antibody fragment in different plant hosts and tissues by using Potato virus X as a vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Modified HPV16 E7 Genes as DNA Vaccine against E7-Containing Oncogenic Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

A launch vector for the production of vaccine antigens in plants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

An E7-based therapeutic vaccine protects mice against HPV16 associated cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Production of recombinant proteins in clonal root cultures using episomal expression vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Engineering DNA vaccines that include plant virus coat proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Antitumor activity of DNA vaccines based on the human papillomavirus-16 E7 protein genetically fused to a plant virus coat protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Potato virus X coat protein fusion to human papillomavirus 16 E7 oncoprotein enhance antigen stability and accumulation in tobacco chloroplast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Ribosome-inactivating proteins: progress and problems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Transient expression of HPV16 E7 peptide (aa 44-60) and HPV16 L2 peptide (aa 108-120) on chimeric potyvirus-like particles using Potato virus X-based vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Phylogenetic studies reveal existence of multiple lineages of a single genotype of DENV-1 (genotype III) in India during 1956–2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Therapeutic human papillomavirus vaccines: current clinical trials and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

Transient expression of Human papillomavirus type 16 L1 protein in Nicotiana benthamiana using an infectious tobamovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERV.10.84

21 January 2018

Identifiers

DOI

10.1586/ERV.10.84

1 reference

23 August 2017

1 reference